Maya is developing and testing a new cancer drug that targets a protein which many aggressive cancers rely on to grow, spread, and resist treatment.
“I hope to help bridge the gap between cancer biology and the development of more effective targeted treatments.”
So far in this series, I’ve talked a lot about the biology of cancer treatment and recurrence. However, in my very first blog post, I invited you to join me on the road of drug development from bench (in the lab) to bedside (in a patient). You may have noticed I haven’t really lived up […]
In my last blog post, we talked about the science of cancer heterogeneity and how it can help explain why therapies don’t work the same for everyone. But what about cancer recurrence? It can look like a treatment has been successful on the outside. The tumours have disappeared and the scans are clear. However, if […]
One of the most confusing parts of cancer treatment is how two people can have the same cancer, receive the same therapy and have totally different experiences. What may work for one person might not work at all for another. I touched on this concept in my last blog post but now I’d like to introduce one of the biggest challenges in cancer research and treatment: heterogeneity. In simple terms, heterogeneity […]
As a cancer researcher, the number one question I am asked is whether I have found “The Cure” yet. The number two question is where I think “they’ve” hidden it. While I (and the hundreds of thousands of other scientists in cancer research) would love to say that I have the answer, I think it’s very unlikely there will ever be one singular cure for all cancers. You […]
